FABP2 and Parkinson disease: For NSAIDs, more modest associations were seen with barrier markers: the serum I-FABP concentration was higher (by 27 [2, 58]%), but faecal AAT lower (by 63 [40, 98]%) (P = 0.04 and = 0.03, PD status adjusted).